Abbott Laboratories · Total Current Liabilities

Latest reported$16.50Bperiod endingDec 31, 2025

ABT FY Current Liabilities ($788.50M → $16.50B)

Annual total current liabilities

High-resolution chart · PNG

ABT total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	16,496,000,000
Dec 31, 2024	14,157,000,000
Dec 31, 2023	13,841,000,000
Dec 31, 2022	15,489,000,000
Dec 31, 2021	13,105,000,000
Dec 31, 2020	11,907,000,000
Dec 31, 2019	10,863,000,000
Dec 31, 2018	9,012,000,000
Dec 31, 2017	8,912,000,000
Dec 31, 2016	6,660,000,000
Dec 31, 2015	9,186,000,000
Dec 31, 2014	10,532,000,000
Dec 31, 2013	9,507,000,000
Dec 31, 2012	13,280,176,000
Dec 31, 2011	15,480,228,000
Dec 31, 2010	17,262,434,000
Dec 31, 2009	13,049,489,000
Dec 31, 2008	11,591,908,000
Dec 31, 2007	9,103,278,000
Dec 31, 2006	11,951,195,000
Dec 31, 2005	7,415,514,000
Dec 31, 2004	6,825,644,000
Dec 31, 2003	7,639,535,000
Dec 31, 2002	7,002,202,000
Dec 31, 2001	7,926,817,000
Dec 31, 2000	4,297,540,000
Dec 31, 1999	4,516,711,000
Dec 31, 1998	4,962,126,000
Dec 31, 1997	5,034,468,000
Dec 31, 1996	4,343,717,000
Dec 31, 1995	3,790,314,000
Dec 31, 1994	3,475,866,000
Dec 31, 1993	3,094,933,000
Dec 31, 1992	2,782,500,000
Dec 31, 1991	2,229,300,000
Dec 31, 1990	2,001,100,000
Dec 31, 1989	1,383,600,000
Dec 31, 1988	1,439,700,000
Dec 31, 1987	1,486,800,000
Dec 31, 1986	1,303,500,000
Dec 31, 1985	788,500,000